Core Insights - Gaxos.ai Inc. has received approval for its product Gaxos Labs for Game Developers and Publishers to be listed on Amazon Web Services (AWS) Marketplace, enhancing its market presence and distribution capabilities [1][2]. Group 1: Product and Market Impact - The listing on AWS Marketplace is a significant milestone in the company's go-to-market strategy, allowing for seamless deployment to millions of AWS customers across 245 countries and territories [2]. - The AWS Marketplace inclusion transforms Gaxos Labs from a standalone SaaS solution into a cloud-native, enterprise-grade service integrated into the AWS ecosystem, thereby expanding its global reach [3]. Group 2: Benefits of AWS Marketplace Inclusion - Key benefits include immediate exposure to all active AWS customers, the ability for AWS customers to use AWS Credits for payment, built-in AWS billing integration, global scalability with automated deployment capabilities, and qualification for co-selling with Amazon's global sales force [7].

Core Insights - Gaxos.ai Inc. has officially launched the AI-enabled Gaxos Health mobile application for iOS and Android, aimed at enhancing individual health outcomes through personalized technology [1][2] - The Gaxos Health app utilizes proprietary algorithms to provide goal-based wellness protocols, including nutrition, fitness, supplementation, and behavioral coaching [2][4] - The CEO of Gaxos, Vadim Mats, emphasized the potential of Gaxos Health in the multi-trillion-dollar health and wellness industry, aiming to deliver value to both users and shareholders [3] Company Overview - Gaxos Health's mission is to optimize human performance by offering customized health and wellness plans that integrate science and technology [4] - The app includes various packages such as biomarker testing, personalized nutrition plans, fitness routines, supplement plans, and live coaching [4][8] - Gaxos.ai Inc. is focused on redefining the human-AI relationship, with offerings that span health, wellness, and gaming [5] Application Features - The Gaxos Health app provides personalized nutrition plans based on macronutrient needs and meal quantity [8] - It creates exercise plans tailored to individual fitness levels and goals [8] - The app encourages the development of core habits like hydration, sleep, and sun exposure, along with habit and meal tracking features to support overall health [8]

Revenue and Financial Performance - In 2024, the company generated revenues of $4,027 from health coaching packages, a significant increase from $256 in 2023[223]. - The net loss for 2024 was $3,424,283, a decrease of $523,814, or 13.3%, compared to a net loss of $3,948,097 in 2023[233]. - The company reported a loss from operations of $3,703,605 in 2024, down from $4,015,285 in 2023, a decrease of $311,680, or 7.8%[231]. - For the year ended December 31, 2024, net cash used in operations was $3,280,397, primarily due to a net loss of $3,424,283[237]. - For the year ended December 31, 2023, net cash used in operations was $2,980,592, with a net loss of $3,948,097[238]. Expenses - Operating expenses decreased by $307,909, or 7.7%, from $4,015,541 in 2023 to $3,707,632 in 2024[224]. - Research and development expenses increased by $80,669, or 8.8%, from $915,818 in 2023 to $996,487 in 2024, primarily due to costs associated with Gaxos Health[225]. - General and administrative expenses totaled $2,711,145 in 2024, down from $3,047,360 in 2023, reflecting a decrease of $336,215[226]. - The company expects to continue generating operating losses in the foreseeable future due to corporate overhead and R&D costs[236]. Cash Flow and Financing - The company reported net cash provided by financing activities of $16,586,051 for the year ended December 31, 2024, mainly from common stock sales and warrant exercises[241]. - The company sold 1,449,277 common shares at $3.45 per share, generating net proceeds of $4,449,055 after fees[235]. - The company raised $3,600,656 from a securities purchase agreement on December 26, 2024, selling 1,346,669 shares at $3.00 each[235]. - Net cash provided by investing activities for the year ended December 31, 2024, was $67,735, resulting from short-term investment sales[239]. Initiatives and Subsidiaries - Gaxos Health, a new initiative, aims to provide AI-driven personalized wellness strategies, integrating biometric data and health goals[215]. - RNK Health, a subsidiary formed in September 2024, focuses on marketing health-related products, including GLP-1 medications[218]. - The company launched four proprietary games in 2023, enhancing user engagement through AI personalization and NFT minting[214]. Shareholder Actions - The company purchased and canceled 6,846 treasury shares for $19,602 at an average price of $2.86 per share in 2024[241]. - As of December 31, 2024, the company had a cash balance of $14,398,099 and working capital of $16,427,618[234]. Future Plans - The company plans to pursue research and development of new products, requiring additional capital from third-party sources[243]. - The company did not have any off-balance sheet arrangements for the years ended December 31, 2024, and 2023[244].

Core Insights - Gaxos.ai Inc. has acquired AI technology to enhance its content creation services, expanding the capabilities of Gaxos Labs and supporting broader AI development initiatives [1][2] - The acquisition introduces advanced AI solutions such as text-to-speech, image generation, video assembly, narration, styling, and script automation, creating new opportunities for users and enterprises [2] - CEO Vadim Mats emphasized that this acquisition strengthens the AI ecosystem of the company and accelerates the development of AI-powered content creation [3] Company Overview - Gaxos.ai Inc. is focused on redefining the human-AI relationship, with applications spanning health, wellness, and gaming, aiming to address issues related to health, longevity, and entertainment through AI solutions [4]

Core Viewpoint - Gaxos.ai Inc. has reincorporated from Delaware to Nevada, a move approved by both the board of directors and stockholders, with no impact on existing contracts or company operations [1][2][3]. Group 1: Reincorporation Details - The reincorporation was approved at the Annual Meeting of stockholders on December 27, 2024 [2]. - The company will continue to operate under the same stock symbol "GXAI" on the Nasdaq Capital Market, and no new stock certificates will be issued [4]. Group 2: Company Operations - The reincorporation does not affect any of the company's contracts with third parties, and all rights and obligations remain intact [3]. - There have been no changes to the Board of Directors, management, business, or operations as a result of the reincorporation [3]. Group 3: Company Overview - Gaxos.ai Inc. focuses on developing artificial intelligence applications in health, wellness, and gaming sectors, aiming to redefine the human-AI relationship [5].

Company Overview - Gaxos.ai Inc. is focused on developing artificial intelligence applications across various sectors, particularly in health, wellness, and gaming [3] - The company aims to redefine the human-AI relationship and is committed to addressing health, longevity, and entertainment through AI solutions [3] Upcoming Event - Gaxos will participate in the Sequire Investor Summit from January 21 to 23, 2025, in San Juan, Puerto Rico [1] - The CEO of Gaxos, Vadim Mats, expressed enthusiasm about presenting the company's initiatives to investors and other participants at the summit [2] - The Sequire Investor Summit is a significant event that will feature over 75 presenting companies and more than 500 investors, funds, family offices, and analysts [2]

Core Viewpoint - Gaxos.ai Inc. has successfully closed a registered direct offering, raising approximately $4 million in gross proceeds, which will be utilized for working capital and general corporate purposes [1][7]. Group 1: Offering Details - The company issued a total of 1,346,669 shares of common stock at a price of $3.00 per share in the offering [2]. - In addition to the common stock, unregistered warrants to purchase an equal number of shares were issued in a concurrent private placement, with an exercise price of $3.00 per share [2][9]. - The offering was conducted under a shelf registration statement filed with the SEC, which became effective on December 18, 2024 [2]. Group 2: Company Objectives - Gaxos.ai aims to redefine the human-AI relationship by expanding its applications into health, wellness, and gaming sectors [4]. - The company is committed to addressing issues related to health, longevity, and entertainment through its AI solutions [4]. Group 3: Financial Information - The total gross proceeds raised by Gaxos.ai in December 2024 amounted to approximately $9 million [7]. - H.C. Wainwright & Co. served as the exclusive placement agent for the offering [8].

Group 1 - Gaxos.ai Inc. has announced a registered direct offering of 1,346,669 shares of common stock at a price of $3.00 per share, with expected gross proceeds of approximately $4 million before fees and expenses [2][1] - The company plans to use the net proceeds from the offering for working capital and other general corporate purposes [1] - In addition to the common stock offering, Gaxos.ai will issue unregistered warrants to purchase an equal number of shares, with an exercise price of $3.00 per share, exercisable upon issuance and expiring three years later [2][5] Group 2 - H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering [3] - The shares are being offered under a shelf registration statement filed with the SEC, which became effective on December 18, 2024 [4] - The warrants and underlying shares have not been registered under the Securities Act and may not be sold in the U.S. without an effective registration statement or applicable exemption [5] Group 3 - Gaxos.ai is focused on developing artificial intelligence applications across various sectors, including health, wellness, and gaming, aiming to redefine the human-AI relationship [7]

Core Insights - Gaxos.ai Inc. has successfully integrated Meshy 4 into its AI solutions for game developers and publishers, enhancing the creation of 3D assets [5][7]. Group 1: Product Features - The Meshy 4 update allows users to fine-tune mesh topology, limit polycounts, and produce higher-quality 3D models more efficiently [1]. - Users can select between quad- or triangle-based mesh structures to improve edge flow, enhance textures, and streamline shading and animation [2]. - The new polycount limitation feature ensures that projects remain efficient and ready for real-time deployment [2]. Group 2: Workflow Improvements - The integration of Meshy 4 accelerates workflows, enabling faster movement from concept to completion without compromising detail or performance [2]. - Improved geometry quality results in cleaner, more polished models, reducing the need for time-consuming revisions [2]. Group 3: Company Overview - Gaxos.ai is focused on developing AI applications across various sectors, including health, wellness, and gaming [3]. - The company aims to redefine the human-AI relationship through its innovative solutions [3].

Core Viewpoint - Gaxos.ai Inc. has successfully closed a registered direct offering and a concurrent private placement, raising approximately $5 million to support its operations and expansion into health, wellness, and gaming sectors [1][2][4]. Group 1: Offering Details - The company issued a total of 1,449,277 shares of common stock at a price of $3.45 per share [1]. - Concurrently, unregistered warrants to purchase up to 1,449,277 shares at an exercise price of $3.32 per share were issued, which are exercisable upon issuance and expire three years later [1][2]. - H.C. Wainwright & Co. served as the exclusive placement agent for the offering [2]. Group 2: Financial Proceeds and Use - The gross proceeds from the offering were approximately $5 million before deducting fees and expenses [2]. - The net proceeds will be utilized for working capital and other general corporate purposes [2]. Group 3: Company Vision and Expansion - Gaxos.ai aims to redefine the human-AI relationship by expanding its offerings to include health, longevity, and entertainment through AI solutions [4].